Intrauterine Devices Market Outlook 2021 | Revenue Models

12/lug/2017 12:49:32 Market Data Forecast Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

The Global Intrauterine devices (IUD's) Market was worth $ 1,400 million in 2016 and estimated to reach $ 1,768 million by the end of 2021 with a growing potential of 4.78%. 


Intrauterine contraceptive devices are small devices, Often T-shaped, containing either levonorgestrel or copper, Which are injected into the uterus. They are an effective type of reversible birth control and are a form of long-acting contraception. This market is predicted to show the modest growth during the forecast period and is influenced by the different regional trends That segment the market When it comes to the availability of different contraceptive devices.


Full report at:


Upcoming trends such as the growing incidence of unintended pregnancies are quickly Gaining popularity as it helps to control healthcare expenditure on gratuitous abortions. Recently, it Has Been Observed That nearly 60% of all pregnancies are unwanted, unintended and are mistimed. Therefore, Governments and non-profit organizations across the world are promoting the use of intrauterine devices, along with family planning, birth control measures to stop unplanned pregnancies. Additionally, the arrangement of various awareness programs by organizations like the ESC,APCOC, IPPF, and FIGO are predicted to amplify the halls of IUDs during the forecast period.


That Major factors influence the growth of the market are advancement in technical innovations, Increasing prevalenceof STD's (Sexually Transmitted Diseases), immediate health benefits other than birth control, Rise in eGovernment Initiatives to prevent unwanted pregnancies and abortions. Restraints That are hindering the growth of the market are Cultural or religious oppositions prevalent in many countries, Economic constraints, Infertility issues, ectopic pregnancy, pelvic inflammatory infection and Limited access to contraception.


Request sample:


The Global Intrauterine Devices market is broadly categorized based on product type into Hormonal intrauterine devices and Copper intrauterine device. Hormonal intrauterine devicesis estimated to have highestmarket share in the market. Since hormonal intrauterine devices haveless complications and risks Compared to non-hormonal intrauterine devices.


Some of the major companies operating in the global market are intrauterine devices Agile Therapeutics, Actavis PLC, ANI Pharmaceuticals, Inc., Bayer, Teva Pharmaceutical, Besins HealthCare, Brecuro Medical, Effik International; Eurogine, HLL Lifecare, HRA Pharma, Lupine Pharmaceuticals, Ltd., Okamato Industries, Inc, Pfizer.


About Market Data Forecast:

The publisher of this report is Market Forecast Data Whose strong lies in Market researchand Business Intelligence. Handling Both individual and corporate clients across multiple business domains they offer syndicated / research customized to suit the client's research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit,



Abhishek Shukla

Sales Manager (International Business Development)

Market Data Forecast

Direct Line: + 1-888-702-9626

Mobile: +91 998 555 0206


Visit MarketDataForecast Blog @


View Latest Press Releases of MDF @

blog comments powered by Disqus è un servizio offerto da Factotum Srl